Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer

NCT00298155 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT00298155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00298155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2006
Completion date
January 31, 2014
Enrollment
35 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, prostate neoplasms